drugset / Trial / NCT03019887
Correlation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose Reduction
NaSingle-groupOpen-labelTreatment
Summary
To reduce antipsychotics to under 1000mg in patients with schizophrenia taking more than 1000mg/day and to evaluate relationship between relapse and cognitive function.
Timeline
- Start
- 2011-04
- Primary completion
- 2017-01
- Completion
- 2017-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aripiprazole | Other / unclassified | — | — |
| Subject | Haloperidol | Other / unclassified | — | — |
| Subject | Levomepromazine | Small molecule | — | — |
| Subject | Olanzapine | Small molecule | — | — |
| Subject | Paliperidone | Unknown | — | — |
| Subject | Perphenazine | Small molecule | — | — |
| Subject | Quetiapine | Small molecule | — | — |
| Subject | Risperidone | Other / unclassified | — | — |